Innovation & intellectual property · 24/02/2023Updated: 10/17/2026 · 1 min read
USPTO and FDA Extend Public Comment Period for Joint Collaboration Initiatives
Summary
The USPTO and FDA are extending the public comment period for their joint collaboration initiatives until March 10, 2023, following the initial publication in the Federal Register on November 7, 2022
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →